Aveanna Healthcare (NASDAQ:AVAH) Upgraded at Stephens

Aveanna Healthcare (NASDAQ:AVAH) was upgraded by investment analysts at Stephens from an “equal weight” rating to an “overweight” rating in a research note issued on Friday. The firm presently has a $11.00 price objective on the stock. Stephens’ price target points to a potential upside of 47.85% from the stock’s previous close.

AVAH has been the topic of several other reports. UBS Group boosted their target price on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, January 15th. Barclays decreased their price objective on Aveanna Healthcare from $11.00 to $9.50 and set an “overweight” rating for the company in a report on Wednesday, March 25th. Zacks Research downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 3rd. BMO Capital Markets cut their target price on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 20th. Finally, Weiss Ratings lowered shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, Aveanna Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $10.33.

Aveanna Healthcare Stock Performance

NASDAQ AVAH opened at $7.44 on Friday. The company has a market capitalization of $1.62 billion, a PE ratio of 7.29 and a beta of 1.93. The company has a debt-to-equity ratio of 6.62, a quick ratio of 1.32 and a current ratio of 1.32. Aveanna Healthcare has a 52-week low of $3.73 and a 52-week high of $10.32. The company has a 50-day simple moving average of $6.71 and a 200 day simple moving average of $7.92.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a net margin of 9.25% and a return on equity of 481.69%. The firm had revenue of $647.92 million for the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare’s revenue was up 15.9% on a year-over-year basis. On average, research analysts predict that Aveanna Healthcare will post 0.56 EPS for the current year.

Insider Activity

In other Aveanna Healthcare news, insider Patrick A. Cunningham sold 18,436 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $132,923.56. Following the sale, the insider directly owned 337,755 shares in the company, valued at $2,435,213.55. This represents a 5.18% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Matthew Buckhalter sold 13,512 shares of the business’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $97,421.52. Following the transaction, the chief financial officer owned 529,243 shares of the company’s stock, valued at $3,815,842.03. This trade represents a 2.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 738,957 shares of company stock worth $5,458,175 in the last three months. Insiders own 5.30% of the company’s stock.

Institutional Trading of Aveanna Healthcare

A number of large investors have recently modified their holdings of AVAH. Caitong International Asset Management Co. Ltd grew its holdings in shares of Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after purchasing an additional 2,400 shares in the last quarter. Quantbot Technologies LP bought a new stake in Aveanna Healthcare during the second quarter valued at approximately $43,000. Summit Securities Group LLC purchased a new position in Aveanna Healthcare in the 1st quarter worth approximately $53,000. Oxford Asset Management LLP bought a new position in shares of Aveanna Healthcare in the 2nd quarter worth $64,000. Finally, Bayesian Capital Management LP bought a new position in shares of Aveanna Healthcare in the 2nd quarter worth $85,000. Institutional investors own 87.96% of the company’s stock.

More Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: AVAH reported Q1 2026 earnings of $0.18 per share, beating estimates of $0.13, while revenue came in at $647.9 million, above the $613.2 million consensus. Article: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance
• Positive Sentiment: The company said revenue rose 15.9% year over year, net income increased to $41.7 million from $5.2 million, and adjusted EBITDA climbed 25.2% to $84.4 million, signaling improving operating momentum. Article: Aveanna Healthcare Shares Climb After Strong Quarterly Results and Higher Guidance
• Positive Sentiment: Management also raised full-year 2026 guidance, boosting revenue outlook to $2.56 billion-$2.58 billion and adjusted EBITDA guidance to $328 million-$332 million, which likely supports investor confidence in the rest of the year. Article: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance
• Neutral Sentiment: Additional coverage from earnings-call summaries and transcripts highlighted the same beat-and-raise results, reinforcing the market’s positive reaction rather than adding new drivers. Article: Aveanna Healthcare Holdings Inc (AVAH) Q1 2026 Earnings Call Highlights

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.